Literature DB >> 29777757

Stem cell-based retina models.

Kevin Achberger1, Jasmin C Haderspeck1, Alexander Kleger2, Stefan Liebau3.   

Abstract

From the early days of cell biological research, the eye-especially the retina-has evoked broad interest among scientists. The retina has since been thoroughly investigated and numerous models have been exploited to shed light on its development, morphology, and function. Apart from various animal models and human clinical and anatomical research, stem cell-based models of animal and human cells of origin have entered the field, especially during the last decade. Despite the observation that the retina of different species comprises endogenous stem cells, most stem cell-related research in the human retina is now based on pluripotent stem cell models. Herein, systems of two-dimensional (2D) cultures and co-cultures of distinctly differentiated retinal subtypes revealed a variety of cellular aspects but have in many aspects been replaced by three-dimensional (3D) structures-the so-called retinal organoids. These organoids not only contain all major retinal cell subtypes compared to the physiological situation, but also show a distinct layering in close proximity to the in vivo morphology. Nevertheless, all these models have inherent advantages and disadvantages, which are expounded and summarized in this review. Finally, we discuss current application aspects of stem cell-based retina models and the specific promises they hold for the future.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Disease modeling; Drug testing; Human iPSC; Mechanistic studies; Optic cup; Optic vesicles; Retinal in vitro models; Retinal organoids; Translation

Mesh:

Year:  2018        PMID: 29777757     DOI: 10.1016/j.addr.2018.05.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  22 in total

1.  Development of High-Resolution Three-Dimensional-Printed Extracellular Matrix Scaffolds and Their Compatibility with Pluripotent Stem Cells and Early Retinal Cells.

Authors:  Arwin Shrestha; Brittany N Allen; Luke A Wiley; Budd A Tucker; Kristan S Worthington
Journal:  J Ocul Pharmacol Ther       Date:  2019-08-16       Impact factor: 2.671

Review 2.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

Review 3.  3D engineering for optic neuropathy treatment.

Authors:  Wenjing Xuan; Aji Alex Moothedathu; Tuo Meng; David C Gibson; Jinhua Zheng; Qingguo Xu
Journal:  Drug Discov Today       Date:  2020-10-07       Impact factor: 7.851

Review 4.  Patient iPSC-derived retinal organoids: Observable retinal diseases in-a-dish.

Authors:  Xiao-Hui Zhang; Zi-Bing Jin
Journal:  Histol Histopathol       Date:  2021-01-22       Impact factor: 2.303

5.  Possibilities for Using Pluripotent Stem Cells for Restoring Damaged Eye Retinal Pigment Epithelium.

Authors:  A E Kharitonov; A V Surdina; O S Lebedeva; A N Bogomazova; M A Lagarkova
Journal:  Acta Naturae       Date:  2018 Jul-Sep       Impact factor: 1.845

6.  A Cleared View on Retinal Organoids.

Authors:  Virginia Cora; Jasmin Haderspeck; Lena Antkowiak; Ulrich Mattheus; Peter H Neckel; Andreas F Mack; Sylvia Bolz; Marius Ueffing; Natalia Pashkovskaia; Kevin Achberger; Stefan Liebau
Journal:  Cells       Date:  2019-04-28       Impact factor: 6.600

7.  Correction of NR2E3 Associated Enhanced S-cone Syndrome Patient-specific iPSCs using CRISPR-Cas9.

Authors:  Laura R Bohrer; Luke A Wiley; Erin R Burnight; Jessica A Cooke; Joseph C Giacalone; Kristin R Anfinson; Jeaneen L Andorf; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Genes (Basel)       Date:  2019-04-05       Impact factor: 4.096

8.  Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.

Authors:  Kevin Achberger; Christopher Probst; Jasmin Haderspeck; Sylvia Bolz; Julia Rogal; Johanna Chuchuy; Marina Nikolova; Virginia Cora; Lena Antkowiak; Wadood Haq; Nian Shen; Katja Schenke-Layland; Marius Ueffing; Stefan Liebau; Peter Loskill
Journal:  Elife       Date:  2019-08-27       Impact factor: 8.140

Review 9.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

Review 10.  Diabetes through a 3D lens: organoid models.

Authors:  Anastasia Tsakmaki; Patricia Fonseca Pedro; Gavin A Bewick
Journal:  Diabetologia       Date:  2020-03-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.